糖尿病设备市场规模、份额和成长分析（按类型、分销管道、最终用途和地区）- 产业预测 2025-2032

预计 2023 年全球糖尿病设备市场规模将达到 333 亿美元，并从 2024 年的 362.3 亿美元增长到 2032 年的 711.4 亿美元，预测期内（2025-2032 年）的复合年增长率为 8.8%。

全球疾病负担不断加剧，主要是由于久坐的生活方式和都市化的加速。根据国际糖尿病联盟通报，全球约有5.3亿20-79岁族群被诊断出患有糖尿病，与多种併发症有关，包括中风、心血管疾病和神经损伤。随着人们对糖尿病管理认识的提高，这种令人担忧的趋势正在刺激对糖尿病管理设备的需求。为了满足日益增长的消费者需求，胰岛素帮浦、胰岛素笔和其他先进的糖尿病治疗技术的创新设计已经应运而生。因此，领先的製造商正专注于创新和开发尖端产品以占领较大的市场占有率，凸显了增强糖尿病护理解决方案的迫切需求。

目录

介绍

• 调查目的
• 研究范围
• 定义

调查方法

• 资讯采购
• 次要和主要资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分机会分析

市场动态及展望

• 市场概况
• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特的分析

主要市场考察

• 关键成功因素
• 竞争程度
• 主要投资机会
• 市场生态系统
• 市场吸引力指数（2024 年）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

糖尿病设备市场规模（按类型和复合年增长率）（2025-2032）

• 市场概况
• BGM 设备
  • 自我监测设备
  • 血糖值仪
  • 试纸
  • 《采血针》
  • 连续血糖监测装置
  • 感应器
  • 发送器
  • 接收器
  • 胰岛素注射装置
  • 泵浦
  • 笔
  • 注射器
  • 喷射注射器

糖尿病设备市场规模（按分销管道和复合年增长率） (2025-2032)

• 市场概况
• 医院药房
• 零售药局
• 糖尿病诊所/中心
• 网路药局
• 其他的

糖尿病设备市场规模（按最终用途和复合年增长率） (2025-2032)

• 市场概况
• 医院
• 诊断中心
• 居家护理

糖尿病设备市场规模（按地区）及复合年增长率（2025-2032）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲国家地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 其他亚太地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲国家
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前 5 家公司对比
• 主要企业市场定位（2024年）
• 主要市场参与者所采用的策略
• 近期市场趋势
• 公司市场占有率分析（2024 年）
• 主要企业简介
  • 公司详细信息
  • 产品系列分析
  • 公司分部份额分析
  • 收益与前一年同期比较对比（2022-2024 年）

主要企业简介

• Medtronic（Ireland）
• Abbott Laboratories（United States）
• DexCom（United States）
• Novo Nordisk（Denmark）
• Becton, Dickinson and Company（United States）
• Roche（Switzerland）
• Insulet（United States）
• Tandem Diabetes Care（United States）
• Ypsomed（Switzerland）
• Sanofi（France）
• Eli Lilly and Company（United States）
• LifeScan（United States）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• Bayer AG（Germany）
• Johnson & Johnson（United States）
• Terumo Corporation（Japan）
• AgaMatrix Holdings（United States）
• ARKRAY USA（United States）
• Nipro Corporation（Japan）

结论和建议

Global Diabetes Device Market size was valued at USD 33.3 billion in 2023 and is poised to grow from USD 36.23 billion in 2024 to USD 71.14 billion by 2032, growing at a CAGR of 8.8% during the forecast period (2025-2032).

The global illness burden is escalating, primarily driven by increased sedentary lifestyles and urbanization. As reported by the International Diabetes Federation, approximately 530 million individuals aged 20 to 79 are diagnosed with diabetes, a condition linked to various complications such as strokes, cardiovascular issues, and nerve damage. This alarming trend is fueling the demand for diabetes management devices, as awareness of disease control intensifies. Innovatively designed insulin pumps, pens, and other advanced diabetic technologies are emerging to meet this growing consumer need. Consequently, leading manufacturers are focusing on technological innovations and developing cutting-edge products to capture significant market share, underscoring the urgent requirement for enhanced diabetes care solutions.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Diabetes Device market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Diabetes Device Market Segments Analysis

Global Diabetes Device Market is segmented by Type, Distribution Channel, End Use and region. Based on Type, the market is segmented into BGM Devices. Based on Distribution Channel, the market is segmented into Hospital Pharmacies, Retail Pharmacies, Diabetes Clinics/Centers, Online Pharmacies and Others. Based on End Use, the market is segmented into Hospitals, Diagnostic Centers and Homecare. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Diabetes Device Market

The global diabetes device market is significantly propelled by the escalating prevalence of diabetes around the world. This surge can be attributed to various factors, including sedentary lifestyles, poor dietary choices, obesity, and an aging demographic. As more individuals receive a diabetes diagnosis, the demand for devices that facilitate effective management and monitoring of the condition intensifies. This growing need underscores the importance of innovative diabetes management technologies, as patients seek solutions to help maintain their health and improve their quality of life in the face of widespread diabetes-related challenges.

Restraints in the Global Diabetes Device Market

The Global Diabetes Device market faces significant restraints related to the accuracy and reliability of its products, which are vital for successful diabetes management. Some devices may present discrepancies in measurements or experience calibration problems and technical malfunctions, all of which can affect the consistency of the data reported. These inaccuracies pose the risk of leading to misguided treatment decisions, ultimately jeopardizing patient safety. To foster confidence among healthcare providers and individuals managing diabetes, it is imperative to prioritize the enhancement of these devices' accuracy and reliability, ensuring they can be trusted to deliver precise readings consistently.

Market Trends of the Global Diabetes Device Market

The Global Diabetes Device market is experiencing a significant trend toward the evolution of insulin delivery systems, characterized by a surge in smart technologies. Insulin pumps and pens are increasingly equipped with advanced features and connectivity options, exemplified by their integration with Continuous Glucose Monitoring (CGM) systems for real-time glucose reading and automated insulin adjustments. This innovation enhances convenience and precision in insulin delivery, enabling personalized treatment plans that markedly improve glycaemic control for patients. As a result, the market is likely to witness accelerated growth as healthcare providers and patients increasingly embrace these cutting-edge solutions for diabetes management.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Diabetes Device Market Size by Type & CAGR (2025-2032)

• Market Overview
• BGM Devices
  • Self-Monitoring Devices
  • Blood Glucose Meters
  • Testing Strips
  • Lancets
  • Continuous Glucose Monitoring Devices
  • Sensors
  • Transmitters
  • Receiver
  • Insulin Delivery Devices
  • Pumps
  • Pens
  • Syringes
  • Jet Injectors

Global Diabetes Device Market Size by Distribution Channel & CAGR (2025-2032)

• Market Overview
• Hospital Pharmacies
• Retail Pharmacies
• Diabetes Clinics/Centers
• Online Pharmacies
• Others

Global Diabetes Device Market Size by End Use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Diagnostic Centers
• Homecare

Global Diabetes Device Market Size & CAGR (2025-2032)

• North America (Type, Distribution Channel, End Use)
  • US
  • Canada
• Europe (Type, Distribution Channel, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Type, Distribution Channel, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Type, Distribution Channel, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Type, Distribution Channel, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Medtronic (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DexCom (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Novo Nordisk (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Roche (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sanofi (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Eli Lilly and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeScan (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AgaMatrix Holdings (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY USA (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Nipro Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations